Quick Takeaways
- SPHERA FUNDS MANAGEMENT LTD. filed SCHEDULE 13G/A for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK).
- Disclosed ownership: 4.7%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"SPHERA FUNDS MANAGEMENT LTD. disclosed 4.7% ownership in Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sphera Funds Management Ltd. | 4.7% | 3,153,856 | 0 | 3,153,856 | /s/ Adi Hanetz | Adi Hanetz / General Counsel | |
| Sphera Global Healthcare GP Ltd. | 4.7% | 3,153,856 | 0 | 3,153,856 | /s/ Adi Hanetz | Adi Hanetz / General Counsel | |
| Sphera Global Healthcare Management LP. | 4.7% | 3,153,856 | 0 | 3,153,856 | /s/ Adi Hanetz | Adi Hanetz / General Counsel |